Determination of aztreonam/ceftazidime-avibactam synergism and proposal of a new methodology for the evaluation of susceptibility in vitro

被引：2

作者：

Collar, Gabriela da Silva ^{[1
,2
,4
]}

Moreira, Natalia Kehl ^{[1
,2
]}

Becker, Julia ^{[1
]}

Barth, Afonso Luis ^{[2
,3
]}

Caierao, Juliana ^{[1
,2
]}

机构：

[1] Univ Fed Rio Grande Do Sul, Fac Farm, Lab Pesquisa Bacteriol Clin LaBaC, Porto Alegre, Brazil

[2] Univ Fed Rio Grande Do Sul, Fac Farm, Programa Posgrad Ciencias Farmaceut, Porto Alegre, Brazil

[3] Hosp Clin Porto Alegre, Lab Pesquisa Resistencia Bacteriana LABRESIS, Porto Alegre, Brazil

[4] Univ Fed Rio Grande Do Sul, Fac Farm, Ave Ipiranga 2752, BR-90610000 Porto Alegre, RS, Brazil

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2024年 / 109卷 / 02期

关键词：

Aztreonam-avibactam; Ceftazidime-avibactam; Enterobacterales; Microelution ATM/CZA; P; aeruginosa; Synergism; CEFTAZIDIME-AVIBACTAM; AZTREONAM; SERINE;

D O I：

10.1016/j.diagmicrobio.2024.116236

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

We proposed a new methodology, the microelution ATM/CZA (mATM/CZA), based on the antibiotic disc elution and the use of resazurin, for rapid (<4h) determination of in vitro susceptibility to aztreonam combined with ceftazidime-avibactam among Enterobacterales. The mATM/CZA presented excellent accuracy with 1.9 %, 98.1 % and 100 % of major error, specificity and sensitivity, respectively. Furthermore, we assessed synergism between aztreonam and ceftazidime-avibactam in Enterobacterales and Pseudomonas aeruginosa, which was observed in 37/55 Enterobacterales and 31/56 P. aeruginosa. As reference methodologies (checkerboard, time-kill curve) are not compatible with the routine of the clinical microbiology laboratories, mATM/CZA is an important alternative to evaluate susceptibility of the combination in a scenario where its clinical use is increasingly important.

引用

页数：8

共 23 条

[21]

Thomas Genara Romero, 2022, Emerg Infect Dis, V28, P1, DOI 10.3201/eid2811.220415

[22] Rapid Aztreonam/Avibactam NP test for detection of aztreonam/avibactam susceptibility/resistance in Enterobacterales [J].

Viguier, Clement ;

Bouvier, Maxime ;

Sadek, Mustafa ;

Kerbol, Auriane ;

Poirel, Laurent ;

Nordmann, Patrice .

JOURNAL OF CLINICAL MICROBIOLOGY, 2023, 61 (10)

[23] Synergistic activity of ceftazidime-avibactam and aztreonam against serine and metallo-β-lactamase-producing gram-negative pathogens [J].

Wenzler, Eric ;

Deraedt, Matthew F. ;

Harrington, Amanda T. ;

Danizger, Larry H. .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2017, 88 (04) :352-354

← 1 2 3 →